ClinicalTrials.Veeva

Menu

Follow-up of GANI_MED Cardio Cohorts (GANIFU-Card)

U

University Medicine Greifswald

Status

Enrolling

Conditions

Chronic Heart Failure
Metabolic Syndrome

Treatments

Other: no intervention, only observational

Study type

Observational

Funder types

Other

Identifiers

NCT02970214
GANIFU-C-001

Details and patient eligibility

About

Follow-up of two hospital-based patient cohorts (heart failure, metabolic comorbidities in CVD), recruited at baseline by the GANI_MED-project (Greifswald Approach to Individualized Medicine). Standardized protocols will be used for the assessment of medical history, laboratory biomarkers, and the collection of various biosamples for bio-banking purposes. Comparisons with the general background population will be performed.

Full description

5-year follow-up of two hospital-based patient cohorts (heart failure, metabolic comorbidities in CVD), recruited at baseline by the GANI_MED-project (Greifswald Approach to Individualized Medicine). Subjects will be comprehensively phenotypes using standardized protocols for the assessment of medical history, laboratory biomarkers, and the collection of various biosamples for bio-banking purposes. A multi-omics based biomarker assessment including genome-wide genotyping, transcriptome, metabolome, and proteome analyses complements the multi-level approach of GANI_MED. Comparisons with the general background population as characterized by the Study of Health in Pomerania (SHIP) will be performed.

Enrollment

1,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participation in baseline examination of GANI_MED cohorts (heart failure, metabolic risk)

Exclusion criteria

  • none

Trial design

1,200 participants in 2 patient groups

Heart Failure
Description:
Patients with chronic heart failure and with/without reduced left ventricular ejection fraction (EF) at baseline (HFrEF, HFmrEF, HFpEF)
Treatment:
Other: no intervention, only observational
Cardiometabolic risk
Description:
Patients with cardiovascular diseases and metabolic risk factors at baseline
Treatment:
Other: no intervention, only observational

Trial contacts and locations

1

Loading...

Central trial contact

Marcus Dörr, MD; Stephan B Felix, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems